Skip to main content
logo
Cara Therapeutics, Inc. (CARA)
15.96
-0.69 (-4.14%)
Inactive · Last trade price on Apr 15, 2025

Cara Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
242840577651754
Market Cap Growth
--30.89%-92.99%-11.37%-13.64%0.26%
Enterprise Value
3130-35400462626
Last Close Price
15.9618.3626.75386.64438.48544.68

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PE Ratio
-----89.65
PS Ratio
3.403.921.9313.7828.285.58
PB Ratio
-5.30-6.090.713.642.863.03
P/TBV Ratio
--0.713.642.863.03

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
4.334.20-9.5520.054.64
EV/EBITDA Ratio
-----111.96
EV/EBIT Ratio
-----116.31

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
-9.68-9.680.760.010.020.02
Debt / EBITDA Ratio
-----0.79
Asset Turnover
0.080.080.140.200.090.54
Inventory Turnover
19.5619.5643.6439.46--
Quick Ratio
10.6710.674.096.399.559.90
Current Ratio
11.0311.034.547.209.8410.55
Return on Equity (ROE)
-270.01%-270.01%-109.80%-44.25%-37.12%3.86%
Return on Assets (ROA)
-41.09%-41.09%-49.30%-25.49%-21.49%1.33%
Return on Invested Capital (ROIC)
-49.77%-49.77%-58.20%-27.92%-22.94%1.51%
Return on Capital Employed (ROCE)
-----2.10%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-291.26%-253.31%-292.78%-14.81%-13.58%1.11%
FCF Yield
-254.66%-221.48%-233.34%-13.65%-9.23%-0.77%
Buyback Yield / Dilution
-1.11%-1.11%-0.92%-5.79%-5.85%-12.29%
SEC Filings: 10-K · 10-Q